New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Supporting smokers with new lung health checks could save thousands of lives

Supporting smokers with new lung health checks could save thousands of lives

by University of NottinghamCredit: Unsplash/CC0 Public DomainResearchers and national cancer charities strongly welcome the UK Government's decision to back National Screening Committee recom
Oncology January 30,2024
Supporting smokers with new lung health checks could save thousands of lives

Supporting smokers with new lung health checks could save thousands of lives

by University of NottinghamCredit: Unsplash/CC0 Public DomainResearchers and national cancer charities strongly welcome the UK Government's decision to back National Screening Committee recom
Oncology January 30,2024
Researchers discover new molecular driver of retinoblastoma

Researchers discover new molecular driver of retinoblastoma

byUT Southwestern Medical CenterInactive remnant of retinoblastoma tumor following successful intra-arterial chemotherapy. Credit: UT Southwestern Medical CenterDespite decades of medical advanc
Oncology January 30,2024
Researchers discover new molecular driver of retinoblastoma

Researchers discover new molecular driver of retinoblastoma

byUT Southwestern Medical CenterInactive remnant of retinoblastoma tumor following successful intra-arterial chemotherapy. Credit: UT Southwestern Medical CenterDespite decades of medical advanc
Oncology January 30,2024
Study: Risk of cancer doubles for people with 'skewed' blood cells

Study: Risk of cancer doubles for people with 'skewed' blood cells

by King's College LondonAge acquired XCI-skew across age groups and time. (A) A histogram displaying the age distribution of the TwinsUK HUMARA cohort (age range: 19–99; median age = 61). (B)
Oncology January 30,2024
Study: Risk of cancer doubles for people with 'skewed' blood cells

Study: Risk of cancer doubles for people with 'skewed' blood cells

by King's College LondonAge acquired XCI-skew across age groups and time. (A) A histogram displaying the age distribution of the TwinsUK HUMARA cohort (age range: 19–99; median age = 61). (B)
Oncology January 30,2024
Research provides critical information about size and growth speed of gliomas

Research provides critical information about size and growth speed of gliomas

by Kelley Luckstein,Mayo ClinicCredit: Mayo ClinicAn important new clue for preventing and treating brain tumors known as gliomas has been identified in research led by the Lunenfeld-Tannenbaum
Oncology January 30,2024
Research provides critical information about size and growth speed of gliomas

Research provides critical information about size and growth speed of gliomas

by Kelley Luckstein,Mayo ClinicCredit: Mayo ClinicAn important new clue for preventing and treating brain tumors known as gliomas has been identified in research led by the Lunenfeld-Tannenbaum
Oncology January 30,2024
Research offers insight into improving efficacy of PD-L1 immunotherapy for cancer patients

Research offers insight into improving efficacy of PD-L1 immunotherapy for cancer patients

by CU Anschutz Medical CampusPD-L1 interactome graphic. Credit: CU Anschutz Medical CampusA new study published in theJNCI: Journal of the National Cancer Institutebrings researchers
Oncology January 30,2024
Research offers insight into improving efficacy of PD-L1 immunotherapy for cancer patients

Research offers insight into improving efficacy of PD-L1 immunotherapy for cancer patients

by CU Anschutz Medical CampusPD-L1 interactome graphic. Credit: CU Anschutz Medical CampusA new study published in theJNCI: Journal of the National Cancer Institutebrings researchers
Oncology January 30,2024
Cooling glioblastoma to room temperature extends survival in preclinical study

Cooling glioblastoma to room temperature extends survival in preclinical study

by Jenny Owen,Emory UniversityConceptual model of a translational device to deliver cytostatic hypothermia for GBM. Representative diagram of a patient with GBM implanted with an envisioned cyto
Oncology January 30,2024
Cooling glioblastoma to room temperature extends survival in preclinical study

Cooling glioblastoma to room temperature extends survival in preclinical study

by Jenny Owen,Emory UniversityConceptual model of a translational device to deliver cytostatic hypothermia for GBM. Representative diagram of a patient with GBM implanted with an envisioned cyto
Oncology January 30,2024
Research confirms unique danger of postpartum breast cancers

Research confirms unique danger of postpartum breast cancers

by Joe Rojas-Burke,Oregon Health & Science UniversitySites of Metastasis by Estrogen Receptor (ER) Status and Time Since Recent Childbirth Group. Analyses included a total of 1787 known meta
Oncology January 30,2024
Research confirms unique danger of postpartum breast cancers

Research confirms unique danger of postpartum breast cancers

by Joe Rojas-Burke,Oregon Health & Science UniversitySites of Metastasis by Estrogen Receptor (ER) Status and Time Since Recent Childbirth Group. Analyses included a total of 1787 known meta
Oncology January 30,2024
Researchers find superantigen mutant can trigger immune response in ovarian cancer cells

Researchers find superantigen mutant can trigger immune response in ovarian cancer cells

by Liu Jia,Chinese Academy of SciencesThe transwell co-culture models of transcriptome experiment. Credit:International Journal of Molecular Sciences(2023). DOI: 10.3390/ijms24141179
Oncology January 30,2024
Researchers find superantigen mutant can trigger immune response in ovarian cancer cells

Researchers find superantigen mutant can trigger immune response in ovarian cancer cells

by Liu Jia,Chinese Academy of SciencesThe transwell co-culture models of transcriptome experiment. Credit:International Journal of Molecular Sciences(2023). DOI: 10.3390/ijms24141179
Oncology January 30,2024
Team reveals specific mechanism for promoting cancer vulnerability to ferroptosis

Team reveals specific mechanism for promoting cancer vulnerability to ferroptosis

by Luisa Hoffmann,Helmholtz Association of German Research CentresCredit: Pixabay/CC0 Public DomainA research team at Helmholtz Munich has revealed a specific mechanism that is able to promote c
Oncology January 30,2024
Team reveals specific mechanism for promoting cancer vulnerability to ferroptosis

Team reveals specific mechanism for promoting cancer vulnerability to ferroptosis

by Luisa Hoffmann,Helmholtz Association of German Research CentresCredit: Pixabay/CC0 Public DomainA research team at Helmholtz Munich has revealed a specific mechanism that is able to promote c
Oncology January 30,2024
Researcher leads first in-human multiple myeloma study with over 90% response rate

Researcher leads first in-human multiple myeloma study with over 90% response rate

by Indiana University School of MedicineMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Indiana University Melvin and Bren
Oncology January 30,2024
Researcher leads first in-human multiple myeloma study with over 90% response rate

Researcher leads first in-human multiple myeloma study with over 90% response rate

by Indiana University School of MedicineMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Indiana University Melvin and Bren
Oncology January 30,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com